(Q36542496)

14 August 2017

Activated partial thromboplastin time and risk of future venous thromboembolism (English)

1 reference

14 August 2017

venous thromboembolism

1 reference

5

Mary Cushman

1 reference

14 August 2017

4

Aaron R Folsom

1 reference

14 August 2017

Neil A Zakai

1

1 reference

14 August 2017

Tetsuya Ohira

series ordinal

2

1 reference

14 August 2017

Richard White

series ordinal

3

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 March 2008

1 reference

American Journal of Medicine

14 August 2017

1 reference

14 August 2017

121

1 reference

14 August 2017

3

1 reference

14 August 2017

231-238

1 reference

Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2295205

Levels of coagulation factors and venous thromboembolism

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2295205

Fibrin fragment D-dimer and the risk of future venous thrombosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2295205

The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2295205

The Cardiovascular Health Study: design and rationale

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2295205

Resistance to activated protein C as a basis for venous thrombosis.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2295205

A comparison of direct adjustment and regression adjustment of epidemiologic measures.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2295205

How independent are "independent" effects? Relative risk estimation when correlated exposures are measured imprecisely.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2295205

Obesity as a risk factor in venous thromboembolism

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2295205

Elevated levels of FVIII:C within families are associated with an increased risk for venous and arterial thrombosis.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2295205

A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2295205

The partial thromboplastin time: defining an era in coagulation

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2295205

Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2295205

Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE).

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2295205

Increased incidence of venous thrombosis in patients with shortened activated partial thromboplastin times and low ratios for activated protein C resistance.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2295205

Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2295205

Short-term intraindividual variability in hemostasis factors. The ARIC Study. Atherosclerosis Risk in Communities Intraindividual Variability Study

21 September 2018

1 reference

12 December 2020

Prediction of recurrent venous thromboembolism by the activated partial thromboplastin time

1 reference

12 December 2020

The Factor VIII acute phase response requires the participation of NFkappaB and C/EBP

1 reference

12 December 2020

Venous thrombosis following the use of intermediate purity FVIII concentrate to treat patients with von Willebrand's disease

1 reference

12 December 2020

Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study

1 reference

12 December 2020

10.1016/J.AMJMED.2007.10.025

Identifiers

DOI

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

18328308

1 reference